TOMT
gene geneOn this page
Also known as COMT2
Summary
TOMT (transmembrane O-methyltransferase, HGNC:55527) is a protein-coding gene on chromosome 11q13.4, encoding Transmembrane O-methyltransferase (Q8WZ04). Catalyzes the O-methylation, and thereby the inactivation, of catecholamine neurotransmitters and catechol hormones.
This gene encodes a catechol-O-methyltransferase that catalyzes the transfer of a methyl group from S-adenosyl-L-methionine to a hydroxyl group of catechols and is essential for auditory and vestibular function. Mutations in this gene have been associated with nonsyndromic deafness. Readthrough transcription is observed across this gene and the adjacent leucine-rich repeat containing 51 gene. A third locus (GeneID:220074) is defined to represent the readthrough transcripts.
Source: NCBI Gene 120356740 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 19 total — 3 pathogenic, 1 likely-pathogenic
- MANE Select transcript:
NM_001393500
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:55527 |
| Approved symbol | TOMT |
| Name | transmembrane O-methyltransferase |
| Location | 11q13.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | COMT2 |
| Ensembl gene | ENSG00000284844 |
| Ensembl biotype | protein_coding |
| Entrez | 120356740 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000541899, ENST00000864603
RefSeq mRNA: 1 — MANE Select: NM_001393500
NM_001393500
CCDS: CCDS91529
Canonical transcript exons
ENST00000541899 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002302030 | 72105924 | 72106210 |
| ENSE00003818163 | 72107923 | 72108119 |
| ENSE00003827728 | 72108605 | 72109596 |
Expression profiles
Bgee: expression breadth broad, 14 present calls, max score 67.31.
Top tissues by expression
107 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 67.31 | gold quality |
| bone marrow cell | CL:0002092 | 44.35 | gold quality |
| ventricular zone | UBERON:0003053 | 43.36 | gold quality |
| ganglionic eminence | UBERON:0004023 | 41.10 | silver quality |
| cortical plate | UBERON:0005343 | 39.74 | gold quality |
| duodenum | UBERON:0002114 | 37.80 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| sural nerve | UBERON:0015488 | 37.13 | gold quality |
| muscle tissue | UBERON:0002385 | 36.97 | silver quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| lymph node | UBERON:0000029 | 30.80 | gold quality |
| adrenal tissue | UBERON:0018303 | 30.70 | gold quality |
| urinary bladder | UBERON:0001255 | 30.05 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.91 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| islet of Langerhans | UBERON:0000006 | 29.36 | silver quality |
| smooth muscle tissue | UBERON:0001135 | 29.05 | silver quality |
| endometrium | UBERON:0001295 | 28.66 | gold quality |
| gall bladder | UBERON:0002110 | 28.46 | gold quality |
| fundus of stomach | UBERON:0001160 | 27.73 | gold quality |
| right testis | UBERON:0004534 | 27.67 | silver quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| testis | UBERON:0000473 | 26.07 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| left testis | UBERON:0004533 | 25.76 | silver quality |
| adult mammalian kidney | UBERON:0000082 | 25.50 | gold quality |
| leukocyte | CL:0000738 | 25.44 | gold quality |
| monocyte | CL:0000576 | 25.23 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.16 |
Regulation
Is transcription factor: no
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tomt | ENSDARG00000115463 |
| mus_musculus | Tomt | ENSMUSG00000078630 |
| rattus_norvegicus | Lrtomt | ENSRNOG00000023434 |
| caenorhabditis_elegans | WBGENE00012518 | |
| caenorhabditis_elegans | WBGENE00021487 | |
| caenorhabditis_elegans | WBGENE00021491 | |
| caenorhabditis_elegans | WBGENE00021492 |
Paralogs (2): COMT (ENSG00000093010), COMTD1 (ENSG00000165644)
Protein
Protein identifiers
Transmembrane O-methyltransferase — Q8WZ04 (reviewed: Q8WZ04)
Alternative names: Catechol O-methyltransferase 2, Protein LRTOMT2
All UniProt accessions (1): A0A2R8Y5M8
UniProt curated annotations — full annotation on UniProt →
Function. Catalyzes the O-methylation, and thereby the inactivation, of catecholamine neurotransmitters and catechol hormones. Required for auditory function. Component of the cochlear hair cell’s mechanotransduction (MET) machinery. Involved in the assembly of the asymmetric tip-link MET complex. Required for transportation of TMC1 and TMC2 proteins into the mechanically sensitive stereocilia of the hair cells. The function in MET is independent of the enzymatic activity.
Subunit / interactions. Interacts with LHFPL5, PCDH15, TMC1, TMC2 and TMIE. Interacts directly with TMC1. The interaction of TOMT with TMC1 and TMC2 is required for the transportation of TMC1/2 into the stereocilia of hair cells.
Subcellular location. Membrane Cytoplasm. Endoplasmic reticulum.
Disease relevance. Deafness, autosomal recessive, 63 (DFNB63) [MIM:611451] A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. The disease is caused by variants affecting the gene represented in this entry.
Miscellaneous. LRRC51 and TOMT were originally considered as alternative reading frames, LRTOMT1 and LRTOMT2 of the same LRTOMT gene in primates.
Similarity. Belongs to the class I-like SAM-binding methyltransferase superfamily. Cation-dependent O-methyltransferase family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8WZ04-1 | 1, D' | yes |
| Q8WZ04-2 | 2, E' |
RefSeq proteins (1): NP_001380429* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002935 | SAM_O-MeTrfase | Family |
| IPR029063 | SAM-dependent_MTases_sf | Homologous_superfamily |
Pfam: PF01596
Catalyzed reactions (Rhea), 1 shown:
- a catechol + S-adenosyl-L-methionine = a guaiacol + S-adenosyl-L-homocysteine + H(+) (RHEA:17877)
UniProt features (15 total): sequence variant 7, binding site 5, chain 1, transmembrane region 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WZ04-F1 | 90.73 | 0.86 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (5): 137; 139–140; 145; 163; 193
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-379397 | Enzymatic degradation of dopamine by COMT |
MSigDB gene sets: 1 (showing top):
chr11q13
GO Biological Process (9): sensory perception of sound (GO:0007605), methylation (GO:0032259), developmental process (GO:0032502), dopamine metabolic process (GO:0042417), dopamine catabolic process (GO:0042420), catecholamine catabolic process (GO:0042424), auditory receptor cell development (GO:0060117), catecholamine metabolic process (GO:0006584), positive regulation of protein import (GO:1904591)
GO Molecular Function (4): catechol O-methyltransferase activity (GO:0016206), methyltransferase activity (GO:0008168), O-methyltransferase activity (GO:0008171), transferase activity (GO:0016740)
GO Cellular Component (4): endoplasmic reticulum (GO:0005783), plasma membrane (GO:0005886), cytoplasm (GO:0005737), apical part of cell (GO:0045177)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Dopamine clearance from the synaptic cleft | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| catecholamine metabolic process | 2 |
| cellular anatomical structure | 2 |
| sensory perception of mechanical stimulus | 1 |
| metabolic process | 1 |
| biological_process | 1 |
| dopamine metabolic process | 1 |
| catecholamine catabolic process | 1 |
| catechol-containing compound catabolic process | 1 |
| biogenic amine catabolic process | 1 |
| inner ear auditory receptor cell differentiation | 1 |
| inner ear receptor cell development | 1 |
| biogenic amine metabolic process | 1 |
| catechol-containing compound metabolic process | 1 |
| protein import | 1 |
| positive regulation of protein transport | 1 |
| regulation of protein import | 1 |
| O-methyltransferase activity | 1 |
| S-adenosylmethionine-dependent methyltransferase activity | 1 |
| transferase activity, transferring one-carbon groups | 1 |
| methyltransferase activity | 1 |
| catalytic activity | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| membrane | 1 |
| cell periphery | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
1440 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TOMT | MAOB | P27338 | 897 |
| TOMT | MAOA | P21397 | 894 |
| TOMT | SLC6A3 | Q01959 | 781 |
| TOMT | DDC | P20711 | 772 |
| TOMT | TH | P07101 | 724 |
| TOMT | SLC6A4 | P31645 | 717 |
| TOMT | DRD4 | P21917 | 699 |
| TOMT | DRD2 | P14416 | 696 |
| TOMT | CYP1B1 | Q16678 | 670 |
| TOMT | DBH | P09172 | 667 |
| TOMT | SHANK2 | Q9UPX8 | 649 |
| TOMT | PNMT | P11086 | 638 |
| TOMT | ANKK1 | Q8NFD2 | 633 |
| TOMT | SLC18A2 | Q05940 | 625 |
| TOMT | BDNF | P23560 | 620 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TOMT | JOSD2 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (6): JOSD2 (Affinity Capture-MS), LRTOMT (Affinity Capture-RNA), JOSD2 (Affinity Capture-MS), LRTOMT (Affinity Capture-RNA), LRTOMT (Affinity Capture-RNA), LRTOMT (Affinity Capture-RNA)
ESM2 similar proteins: A0A193KX02, A0A397HK53, A1Y9I9, A4IG53, A5WWC6, B6CZ46, B6CZ56, B6CZ62, B8NR70, L0TAD5, O42898, P37059, P55205, P58781, P86243, Q0IIS3, Q0P464, Q28C60, Q28DI5, Q2KHV5, Q2VQV9, Q32LS6, Q3V1F8, Q4V339, Q5JTY5, Q5RIA9, Q5XI69, Q5XI79, Q66KL0, Q68EZ3, Q6DCK1, Q6GQ37, Q6PE54, Q6Q2C2, Q6TL19, Q7L592, Q7L5L3, Q8IUF1, Q8IX18, Q8NKC1
Diamond homologs: A0A193KX02, A1Y9I9, A4IG53, A7MBI7, B6CZ46, B6CZ56, B6CZ62, F4ZGF2, G8T6H8, L0TAD5, O42898, O88587, P21964, P22734, P86243, Q00719, Q5H879, Q8NKC1, Q8WZ04, Q99028, B8NI24, O07431, Q9YDA1, A2BKH8, O26915, O27962, Q57636, Q86VU5, Q8TYL4, A6TCI9, B2RK25, B5XNG1, O32036, Q7MVG0, Q8A9H7, Q9XGD5, S5DQS6, Q9ZTT5, A0A0S2UWA5, A0A0S2UWC9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
19 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 3 |
| Likely pathogenic | 1 |
| Uncertain significance | 10 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (4)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1804950 | NM_001145308.5(LRTOMT):c.199C>T (p.Arg67Ter) | Pathogenic |
| 3601215 | NM_001145308.5(LRTOMT):c.307del (p.Asp103fs) | Pathogenic |
| 546 | NM_001145308.5(LRTOMT):c.333C>G (p.Tyr111Ter) | Pathogenic |
| 3601214 | NM_001145308.5(LRTOMT):c.242G>C (p.Arg81Pro) | Likely pathogenic |
SpliceAI
1168 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:72108603:AGGT:A | acceptor_gain | 1.0000 |
| 11:72108604:GGTG:G | acceptor_gain | 1.0000 |
| 11:72110219:CATAG:C | acceptor_gain | 1.0000 |
| 11:72110221:TAGTG:T | acceptor_gain | 1.0000 |
| 11:72110222:AGTG:A | acceptor_gain | 1.0000 |
| 11:72110223:GTG:G | acceptor_gain | 1.0000 |
| 11:72110224:TG:T | acceptor_gain | 1.0000 |
| 11:72110224:TGCT:T | acceptor_loss | 1.0000 |
| 11:72110226:C:A | acceptor_loss | 1.0000 |
| 11:72110226:C:CC | acceptor_gain | 1.0000 |
| 11:72110227:T:A | acceptor_loss | 1.0000 |
| 11:72110539:CTCA:C | donor_loss | 1.0000 |
| 11:72110540:TCAC:T | donor_loss | 1.0000 |
| 11:72110541:CACCT:C | donor_loss | 1.0000 |
| 11:72110542:A:AC | donor_gain | 1.0000 |
| 11:72110542:A:C | donor_loss | 1.0000 |
| 11:72110543:C:CC | donor_gain | 1.0000 |
| 11:72110543:CCT:C | donor_gain | 1.0000 |
| 11:72105969:ATT:A | acceptor_gain | 0.9900 |
| 11:72105986:T:TA | acceptor_gain | 0.9900 |
| 11:72106206:CAAAG:C | donor_loss | 0.9900 |
| 11:72106207:AAAGG:A | donor_loss | 0.9900 |
| 11:72106209:AGG:A | donor_loss | 0.9900 |
| 11:72106211:GTC:G | donor_loss | 0.9900 |
| 11:72106212:T:G | donor_loss | 0.9900 |
| 11:72108599:CCACA:C | acceptor_loss | 0.9900 |
| 11:72108600:CACA:C | acceptor_loss | 0.9900 |
| 11:72108601:ACAGG:A | acceptor_loss | 0.9900 |
| 11:72108602:CA:C | acceptor_loss | 0.9900 |
| 11:72108603:A:AG | acceptor_gain | 0.9900 |
AlphaMissense
1616 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:72108807:T:C | F220S | 0.989 |
| 11:72107992:G:A | G110E | 0.987 |
| 11:72108723:T:C | L192P | 0.984 |
| 11:72108903:T:C | L252P | 0.983 |
| 11:72108836:T:G | Y230D | 0.981 |
| 11:72108774:C:A | A209D | 0.974 |
| 11:72106165:T:A | W72R | 0.972 |
| 11:72106165:T:C | W72R | 0.972 |
| 11:72108897:C:A | A250D | 0.972 |
| 11:72108768:T:A | V207E | 0.971 |
| 11:72108639:T:C | I164T | 0.969 |
| 11:72108837:A:C | Y230S | 0.969 |
| 11:72108639:T:A | I164N | 0.966 |
| 11:72108806:T:C | F220L | 0.964 |
| 11:72108808:C:A | F220L | 0.964 |
| 11:72108808:C:G | F220L | 0.964 |
| 11:72108836:T:A | Y230N | 0.962 |
| 11:72108639:T:G | I164S | 0.960 |
| 11:72108903:T:A | L252H | 0.960 |
| 11:72107971:T:C | L103P | 0.958 |
| 11:72108807:T:G | F220C | 0.957 |
| 11:72106208:A:T | K86I | 0.955 |
| 11:72107991:G:A | G110R | 0.955 |
| 11:72107991:G:C | G110R | 0.955 |
| 11:72105983:C:G | P11R | 0.954 |
| 11:72108684:T:A | V179E | 0.951 |
| 11:72106167:G:C | W72C | 0.950 |
| 11:72106167:G:T | W72C | 0.950 |
| 11:72107971:T:G | L103R | 0.950 |
| 11:72108046:C:T | T128I | 0.950 |
dbSNP variants (sampled 300 via entrez): RS1001585414 (11:72104907 T>A,C), RS1003700981 (11:72108810 T>C,G), RS1004173882 (11:72104013 C>G,T), RS1005768038 (11:72108834 G>A), RS1005820299 (11:72109171 T>C), RS1005909665 (11:72109348 G>T), RS1006100075 (11:72107401 G>A), RS1006458849 (11:72109716 G>C), RS1007526596 (11:72106330 CTT>C,CT,CTTT), RS1008617007 (11:72109576 A>G), RS1009316091 (11:72104632 ACT>A), RS1010045590 (11:72109758 T>C), RS1010685773 (11:72109745 G>A,T), RS1012740858 (11:72106443 G>C), RS1012991988 (11:72105594 G>A)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:611451
GenCC curated gene-disease
Mondo (1): autosomal recessive nonsyndromic hearing loss 63 (MONDO:0012670)
Orphanet (1): Rare autosomal recessive non-syndromic sensorineural deafness type DFNB (Orphanet:90636)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C566951 | Deafness, Autosomal Recessive 63 (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): autosomal recessive nonsyndromic hearing loss 63